Water Exchange Rate Constant as a Biomarker of Treatment Efficacy in Patients With Brain Metastases Undergoing Stereotactic Radiosurgery
Creators
- 1. Physical Sciences, Sunnybrook Research Institute, Toronto, Ontario (Canada)
- 2. Medical Biophysics, University of Toronto, Toronto, Ontario (Canada)
- 3. Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario (Canada)
- 4. Computer Science Department, University College London, London (United Kingdom)
- 5. Neurosurgery and Pediatric Neurosurgery, Medical University, Lublin (Poland)
- 6. Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, Ontario (Canada)
Description
Purpose: This study was designed to evaluate whether changes in metastatic brain tumors after stereotactic radiosurgery (SRS) can be seen with quantitative MRI early after treatment. Methods and Materials: Using contrast-enhanced MRI, a 3-water-compartment tissue model consisting of intracellular (I), extracellular-extravascular (E), and vascular (V) compartments was used to assess the intra–extracellular water exchange rate constant (kIE), efflux rate constant (kep), and water compartment volume fractions (M0,I, M0,E, M0,V). In this prospective study, 19 patients were MRI-scanned before treatment and 1 week and 1 month after SRS. The change in model parameters between the pretreatment and 1-week posttreatment scans was correlated to the change in tumor volume between pretreatment and 1-month posttreatment scans. Results: At 1 week kIE differentiated (P<.001) tumors that had partial response from tumors with stable and progressive disease, and a high correlation (R=−0.76, P<.001) was observed between early changes in the kIE and tumor volume change 1 month after treatment. Other model parameters had lower correlation (M0,E) or no correlation (kep, M0,V). Conclusions: This is the first study that measured kIE early after SRS, and it found that early changes in kIE (1 week after treatment) highly correlated with long-term tumor response and could predict the extent of tumor shrinkage at 1 month after SRS.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.ijrobp.2017.01.016Additional details
Identifiers
- DOI
- 10.1016/j.ijrobp.2017.01.016;
- PII
- S0360-3016(17)30020-2;
Publishing Information
- Journal Title
- International Journal of Radiation Oncology, Biology and Physics
- Journal Volume
- 98
- Journal Issue
- 1
- Journal Page Range
- p. 47-55
- ISSN
- 0360-3016
- CODEN
- IOBPD3
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 48098564
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- BIOLOGICAL MARKERS; BRAIN; CORRELATIONS; FOREIGN EXCHANGE RATE; NEOPLASMS; NMR IMAGING; PATIENTS; RADIOTHERAPY; REACTION KINETICS; SURGERY
- Descriptors DEC
- BODY; CENTRAL NERVOUS SYSTEM; DIAGNOSTIC TECHNIQUES; DISEASES; KINETICS; MEDICINE; NERVOUS SYSTEM; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; THERAPY
Optional Information
- Copyright
- Copyright (c) 2017 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.